---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-031792"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T06:00:57.417937+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Olema CFO/COO Kovacs departs Jan 30; CEO Bohen interim principal financial officer

## Summary
- Shane Kovacs, COO and CFO, leaves Jan 30, 2026; not due to disagreement with company on financial operations.
- Kovacs receives $621,283 lump sum: $562,640 salary, $23,443 prorated 2026 bonus, $35,200 COBRA.
- Outstanding equity awards continue vesting while he consults through Aug 1, 2026.
- CEO Sean Bohen, M.D., Ph.D., assumes interim principal financial officer role; search for permanent CFO launched.

## SEC filing metadata
- accession: 0001193125-26-031792
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000119312526031792/0001193125-26-031792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000119312526031792/d126625d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-031792
- JSON: https://secwatch.observer/filing/0001193125-26-031792.json
- Plain text: https://secwatch.observer/filing/0001193125-26-031792.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.